Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lucentis vs Mitomycin C in Trabeculectomy
NCT00626782Phase 3Completed
- Sponsor
- Wills Eye Hospital
- Start
- Jan 2008
- Primary completion
- Apr 2011
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of ranibizumab in Glaucoma, sponsored by Wills Eye Hospital. Started Jan 2008; status: completed.
02
Drugs
ranibizumab
03
Conditions
Glaucoma
Beyond the preview
Go deeper on NCT00626782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00626782.